|
Anixa Biosciences, Inc. (ANIX) DCF -Bewertung
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Anixa Biosciences, Inc. (ANIX) Bundle
Erforschen Sie das finanzielle Potenzial von Anixa Biosciences, Inc. (ANIX) mit unserem benutzerfreundlichen DCF-Taschenrechner! Geben Sie Ihre Projektionen für Wachstum, Margen und Kosten ein, um den inneren Wert von Anixa Biosciences, Inc. (ANIX) zu berechnen und Ihren Investitionsansatz zu verbessern.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .5 | 2,469.0 | .2 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 0 | 481656.1 | -99.99 | -100 | -25 | -25 | -25 | -25 | -25 |
| EBITDA | -10.0 | -13.1 | -13.7 | -11.0 | -13.8 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | 100 | -2552.44 | -0.55606 | -5221.43 | 100 | -0.11121 | -0.11121 | -0.11121 | -0.11121 | -0.11121 |
| Depreciation | .1 | .1 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 100 | 11.68 | 0.00170109 | 21.9 | 100 | 46.72 | 46.72 | 46.72 | 46.72 | 46.72 |
| EBIT | -10.1 | -13.1 | -13.8 | -11.0 | -13.8 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | 100 | -2564.12 | -0.55776 | -5243.33 | 100 | -0.11155 | -0.11155 | -0.11155 | -0.11155 | -0.11155 |
| Total Cash | 9.1 | 35.7 | 29.7 | 23.8 | 19.9 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .0 | .3 | .2 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 100 | 0 | 0 | 128.57 | 100 | 60 | 60 | 60 | 60 | 60 |
| Inventories | -2.6 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 100 | 0 | -0.0018631 | 0 | 100 | 40 | 40 | 40 | 40 | 40 |
| Accounts Payable | .2 | .1 | .3 | .2 | .5 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 100 | 26.54 | 0.01073309 | 98.1 | 100 | 64.93 | 64.93 | 64.93 | 64.93 | 64.93 |
| Capital Expenditure | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | 100 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -10.1 | -13.0 | -13.5 | -10.9 | -13.8 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -7.2 | -15.6 | -13.3 | -11.2 | -13.4 | -.4 | .0 | .0 | .0 | .0 |
| WACC, % | 8.42 | 8.42 | 8.42 | 8.42 | 8.42 | 8.42 | 8.42 | 8.42 | 8.42 | 8.42 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -.3 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | 0 | |||||||||
| Net Debt | -1 | |||||||||
| Equity Value | 1 | |||||||||
| Diluted Shares Outstanding, MM | 32 | |||||||||
| Equity Value Per Share | 0.02 |
What You Will Get
- Editable Forecast Inputs: Easily modify key assumptions (growth %, margins, WACC) to explore different scenarios.
- Real-World Data: Anixa Biosciences, Inc. (ANIX) financial data pre-filled to kickstart your analysis.
- Automatic DCF Outputs: The template automatically calculates Net Present Value (NPV) and intrinsic value for your convenience.
- Customizable and Professional: A refined Excel model designed to meet your valuation requirements.
- Built for Analysts and Investors: Perfect for testing projections, validating strategies, and enhancing efficiency.
Key Features
- Comprehensive Data: Anixa Biosciences’ historical financial statements and pre-filled projections.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and EBITDA margins as needed.
- Real-Time Insights: View Anixa’s intrinsic value recalculating live.
- Intuitive Visual Outputs: Dashboard graphs showcase valuation results and essential metrics.
- Designed for Precision: A professional-grade tool for analysts, investors, and finance professionals.
How It Works
- Download: Obtain the pre-configured Excel file featuring Anixa Biosciences, Inc.'s (ANIX) financial data.
- Customize: Modify projections, such as revenue growth, EBITDA %, and WACC.
- Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
- Test Scenarios: Generate various forecasts and instantly compare the results.
- Make Decisions: Leverage the valuation insights to inform your investment strategy.
Why Choose This Calculator for Anixa Biosciences (ANIX)?
- Accurate Data: Utilize real Anixa financials for dependable valuation outcomes.
- Customizable: Tailor essential parameters like growth rates, WACC, and tax rates to fit your forecasts.
- Time-Saving: Ready-made calculations save you from starting from the ground up.
- Professional-Grade Tool: Crafted for investors, analysts, and consultants in the biotech sector.
- User-Friendly: Easy-to-navigate design and clear instructions ensure accessibility for all users.
Who Should Use This Product?
- Investors: Evaluate Anixa Biosciences' valuation before making investment decisions.
- CFOs and Financial Analysts: Optimize valuation methodologies and assess financial forecasts.
- Startup Founders: Gain insights into how biotech companies like Anixa Biosciences are appraised.
- Consultants: Provide expert valuation analyses and reports for clients in the biotech sector.
- Students and Educators: Utilize real data to learn and teach valuation strategies in biotechnology.
What the Template Contains
- Pre-Filled Data: Features Anixa Biosciences' historical financials and projections.
- Discounted Cash Flow Model: Editable DCF valuation model with automated calculations.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC using custom inputs.
- Key Financial Ratios: Assess Anixa's profitability, efficiency, and leverage metrics.
- Customizable Inputs: Easily modify revenue growth, margins, and tax rates.
- Clear Dashboard: Visuals and tables summarizing essential valuation outcomes.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.